These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17455662)

  • 21. The problems in the outer membrane permeability and the antibiotic resistance of Pseudomonas aeruginosa.
    Nakae T
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):115-21. PubMed ID: 1667326
    [No Abstract]   [Full Text] [Related]  

  • 22. Carbapenem resistance mediated by blaOXA-181 in Pseudomonas aeruginosa.
    Meunier D; Doumith M; Findlay J; Mustafa N; Mallard K; Anson J; Panagea S; Pike R; Wright L; Woodford N; Hopkins KL
    J Antimicrob Chemother; 2016 Jul; 71(7):2056-7. PubMed ID: 27009032
    [No Abstract]   [Full Text] [Related]  

  • 23. Metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in Brazil.
    Viana Vieira V; Lourenço da Fonseca E; Paulo Vincente AC
    Clin Microbiol Infect; 2005 Nov; 11(11):937. PubMed ID: 16216114
    [No Abstract]   [Full Text] [Related]  

  • 24. Outbreak of Pseudomonas aeruginosa producing IMP-9-type metallo-beta-lactamase in Guangzhou, China.
    Chao Z; Xiao-Feng W; Dan-Hong S; Jin-Ping Y; Nan-Shan Z
    Int J Antimicrob Agents; 2008 Oct; 32(4):363-5. PubMed ID: 18619819
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation of beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea.
    Suk SE; Yoo JS; Lee JK; Lee KM; Chung GT; Shin ES; Han SY; Lee SH; Kim J; Lee YS
    J Microbiol Biotechnol; 2007 Oct; 17(10):1733-7. PubMed ID: 18156795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey.
    Bahar G; Mazzariol A; Koncan R; Mert A; Fontana R; Rossolini GM; Cornaglia G
    J Antimicrob Chemother; 2004 Jul; 54(1):282-3. PubMed ID: 15190017
    [No Abstract]   [Full Text] [Related]  

  • 27. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
    Kunz AN; Brook I
    Chemotherapy; 2010; 56(6):492-500. PubMed ID: 21099222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran.
    Khosravi AD; Mihani F
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):125-8. PubMed ID: 17900848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the metallo-beta-lactamase gene in multidrug-resistant Pseudomonas aeruginosa isolated at Showa University Hospital].
    Shinoda Y; Tomita A; Itaya K; Chen G; Wakuta R; Fukuchi K; Gomi K
    Rinsho Byori; 2006 Jul; 54(7):699-705. PubMed ID: 16913660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro.
    Kobayashi Y; Sumitani Y; Sugita K; Aikawa N
    Int J Antimicrob Agents; 2007 Dec; 30(6):563-4. PubMed ID: 17900870
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Fujimura S; Takane H; Nakano Y; Watanabe A
    J Antimicrob Chemother; 2009 Nov; 64(5):1115-6. PubMed ID: 19744981
    [No Abstract]   [Full Text] [Related]  

  • 33. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of blaVIM-2 carbapenemase in Pseudomonas aeruginosa in Ireland.
    Walsh F; Rogers TR
    J Antimicrob Chemother; 2008 Jan; 61(1):219-20. PubMed ID: 18024489
    [No Abstract]   [Full Text] [Related]  

  • 35. Imipenem-resistant Pseudomonas aeruginosa strains carry metallo-beta-lactamase gene bla(VIM) in a level I Iranian burn hospital.
    Bahar MA; Jamali S; Samadikuchaksaraei A
    Burns; 2010 Sep; 36(6):826-30. PubMed ID: 20045260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
    Dong F; Xu XW; Song WQ; Lü P; Yu SJ; Yang YH; Shen XZ
    Chin Med J (Engl); 2008 Sep; 121(17):1611-6. PubMed ID: 19024085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of KPC-2-producing Pseudomonas aeruginosa isolates in China.
    Ge C; Wei Z; Jiang Y; Shen P; Yu Y; Li L
    J Antimicrob Chemother; 2011 May; 66(5):1184-6. PubMed ID: 21393139
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibiotic resistant Pseudomonas aeruginosa].
    Gotoh N
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():196-201. PubMed ID: 12717971
    [No Abstract]   [Full Text] [Related]  

  • 39. [Multi-drug resistant Pseudomonas aeruginosa infection].
    Tomono K; Sawai T; Kohno S
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):198-201. PubMed ID: 10088373
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
    Cao B; Wang H; Sun H; Zhu Y; Chen M
    J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.